Inventor · disambiguated record
Xu Meng
Also filed as: MENG XU
7 granted patents·4 pending applications·30 citations·filing 2002–2024
84Inventor score
Top patents by PatentIndex Score
11 records- 0189US9314461B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2013·Granted Apr 19, 2016·9 cites·40 claims
- 0289US8524276B2Oral formulations and lipophilic salts of methylnaltrexoneSHAH SYED M·Filed 2011·Granted Sep 3, 2013·11 cites·27 claims
- 0387US8956651B2Oral formulations and lipophilic salts of methylnal trexoneWYETH LLC·Filed 2013·Granted Feb 17, 2015·6 cites·31 claims
- 0484US10307417B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Jun 4, 2019·2 cites·29 claims
- 0580US10507206B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Granted Dec 17, 2019·1 cites·25 claims
- 0679US10376505B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Aug 13, 2019·1 cites·30 claims
- 0777US2020121673A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Application pending·0 cites
- 0872US2024350809A1Nerve stimulation systemGALVANI BIOELECTRONICS LTD·Filed 2024·Application pending·0 cites
- 0959US2016206612A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2016·Application pending·0 cites
- 1058US12036413B2Nerve stimulation systemGALVANI BIOELECTRONICS LTD·Filed 2019·Granted Jul 16, 2024·0 cites·18 claims
- 1138US2003055058A1Combination of a PTPase inhibitor and an ACE inhibitorWYETH CORP·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xu Meng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →